sb 203580 has been researched along with chlormethiazole in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (chlormethiazole) | Trials (chlormethiazole) | Recent Studies (post-2010) (chlormethiazole) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 811 | 83 | 48 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hjertén, A; Ingelman-Sundberg, M; Porsmyr-Palmertz, M; Simi, A; Tindberg, N | 1 |
1 other study(ies) available for sb 203580 and chlormethiazole
| Article | Year |
|---|---|
The neuroprotective agents chlomethiazole and SB203580 inhibit IL-1beta signalling but not its biosynthesis in rat cortical glial cells.
Topics: Animals; Anti-Inflammatory Agents; Blotting, Northern; Blotting, Western; Cells, Cultured; Cerebral Cortex; Chlormethiazole; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Feedback, Physiological; Imidazoles; Interleukin-1; Lipopolysaccharides; Mitogen-Activated Protein Kinases; Neuroglia; Neuroprotective Agents; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-fos; Pyridines; Rats; RNA, Messenger; Signal Transduction | 2002 |